✦ LIBER ✦

HER2 status in advanced breast cancer: which option for aromatase inhibitors?

✍ Scribed by A. Bertolini; G. Scognamiglio; O. Fusco; G. Andreola; A. Fasolo; A. Ardizzoia; M. Giordano; S. Brugnatelli; V. Filippazzi; A. Scanni

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aromatase inhibitors in advanced breast

✍ Henning T. Mouridsen 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 323 KB

Postmenopausal advanced breast cancer: O

✍ D. Dodwell; A. Wardley; S. Johnston 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 184 KB

Aromatase inhibitors for therapy of adva

✍ James N. Ingle; Vera J. Suman 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB

HER-2 status in locally advanced breast

✍ C. Doran; D.A. Cameron; A.D. Watters; R.C.F. Leonard; J.M.S. Bartlett 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Recent advances in aromatase inhibitor t

✍ Vasily J. Assikis; Aman Buzdar 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Dual HER1/HER2 inhibitor lapatinib in ad

✍ Jame Abraham 📂 Article 📅 2007 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 127 KB